Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoko Takasu

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 15, 2019
[Present and Future of an iPS Cell Stock for Regenerative Medicine]Tadaaki Hanatani, Naoko Takasu
Stem Cell Research|January 14, 2021
CiRA iPSC seed stocks (CiRA's iPSC Stock Project)Tadaaki Hanatani, Naoko Takasu
Inflammation and Regeneration|September 10, 2019
Overview: an iPS cell stock at CiRAMasafumi Umekage, Yoshiko Sato, Naoko Takasu
Med (New York, N.Y.)|November 17, 2022
A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese populationShinsuke Yoshida, Tomoaki M Kato, Yoshiko Sato, et al.
Stem Cells Translational Medicine|August 3, 2021
Transplantation of human autologous synovial mesenchymal stem cells with trisomy 7 into the knee joint and 5 years of follow-upMitsuru Mizuno, Kentaro Endo, Hisako Katano, et al.
Molecular Therapy. Methods & Clinical Development|June 27, 2022
Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical applicationYuko Kitano, Sayaka Nishimura, Tomoaki M Kato, et al.
Cell Reports. Medicine|January 14, 2025
A first-in-human clinical study of an allogenic iPSC-derived corneal endothelial cell substitute transplantation for bullous keratopathyMasatoshi Hirayama, Shin Hatou, Masaki Nomura, et al.
Cell Reports Methods|November 30, 2022
Improved Sendai viral system for reprogramming to naive pluripotencyAkira Kunitomi, Ryoko Hirohata, Vanessa Arreola, et al.
Stem Cells Translational Medicine|April 21, 2022
Correlation Between Genetic Abnormalities in Induced Pluripotent Stem Cell-Derivatives and Abnormal Tissue Formation in Tumorigenicity TestsTakako Yamamoto, Yoji Sato, Satoshi Yasuda, et al.
Cancer Science|March 6, 2020
Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cellsTatsuki Ueda, Ayako Kumagai, Shoichi Iriguchi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 15, 2019
[Present and Future of an iPS Cell Stock for Regenerative Medicine]Tadaaki Hanatani, Naoko Takasu
Stem Cell Research|January 14, 2021
CiRA iPSC seed stocks (CiRA's iPSC Stock Project)Tadaaki Hanatani, Naoko Takasu
Inflammation and Regeneration|September 10, 2019
Overview: an iPS cell stock at CiRAMasafumi Umekage, Yoshiko Sato, Naoko Takasu
Med (New York, N.Y.)|November 17, 2022
A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese populationShinsuke Yoshida, Tomoaki M Kato, Yoshiko Sato, et al.
Stem Cells Translational Medicine|August 3, 2021
Transplantation of human autologous synovial mesenchymal stem cells with trisomy 7 into the knee joint and 5 years of follow-upMitsuru Mizuno, Kentaro Endo, Hisako Katano, et al.
Molecular Therapy. Methods & Clinical Development|June 27, 2022
Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical applicationYuko Kitano, Sayaka Nishimura, Tomoaki M Kato, et al.
Cell Reports. Medicine|January 14, 2025
A first-in-human clinical study of an allogenic iPSC-derived corneal endothelial cell substitute transplantation for bullous keratopathyMasatoshi Hirayama, Shin Hatou, Masaki Nomura, et al.
Cell Reports Methods|November 30, 2022
Improved Sendai viral system for reprogramming to naive pluripotencyAkira Kunitomi, Ryoko Hirohata, Vanessa Arreola, et al.
Stem Cells Translational Medicine|April 21, 2022
Correlation Between Genetic Abnormalities in Induced Pluripotent Stem Cell-Derivatives and Abnormal Tissue Formation in Tumorigenicity TestsTakako Yamamoto, Yoji Sato, Satoshi Yasuda, et al.
Cancer Science|March 6, 2020
Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cellsTatsuki Ueda, Ayako Kumagai, Shoichi Iriguchi, et al.
Pageof 2